GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmunoPrecise Antibodies Ltd (NAS:IPA) » Definitions » Deferred Policy Acquisition Costs

IPA (ImmunoPrecise Antibodies) Deferred Policy Acquisition Costs


View and export this data going back to 2010. Start your Free Trial

What is ImmunoPrecise Antibodies Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


ImmunoPrecise Antibodies Business Description

Traded in Other Exchanges
Address
Industrious 823 Congress Avenue, Suite 300, Austin, TX, USA, 78701
ImmunoPrecise Antibodies Ltd is a techbio company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. IPA has several subsidiaries in North America and Europe.